TY - JOUR
T1 - Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New York
AU - Hannan, Edward L.
AU - Farrell, Louise Szypulski
AU - Walford, Gary
AU - Berger, Peter B.
AU - Stamato, Nicholas J.
AU - Venditti, Ferdinand J.
AU - Jacobs, Alice K.
AU - Holmes, David R.
AU - Sharma, Samin
AU - King, Spencer B.
N1 - Funding Information:
This study was funded in part by the New York State Department of Health . Dr. Berger has received consultant fees from Medicure and Janssen Pharmaceuticals; and funding as an investigator for the Geisinger Clinic from AstraZeneca, The Medicines Company, Bristol-Myers Squibb, sanofi-aventis, and Eli Lilly and Company/Daiichi Sankyo . Dr. Jacobs is Site PI on the Xience V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study. Dr. Sharma is on the Speaker's Bureau of Boston Scientific, Abbott Vascular, Angioscore, Eli Lilly and Company/Daiichi Sankyo, and The Medicines Company. Dr. King has received consulting fees from Merck & Company, Wyeth Pharmaceuticals, nContact Surgical, Medtronic, and Celonova Biosciences; and is the editor-in-chief of JACC: Cardiovascular Interventions. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2014/3
Y1 - 2014/3
N2 - Objectives: This study sought to determine the utilization and outcomes for radial access for percutaneous coronary intervention (PCI) for ST-segment elevation acute myocardial infarction (STEMI) in common practice. Background: Radial access for PCI has been studied considerably, but mostly in clinical trials. Methods: All patients undergoing PCI for STEMI in 2009 to 2010 in New York were studied to determine the frequency and the patient-level predictors of radial access. Differences in in-hospital/30-day mortality between radial and femoral access were also studied. Results: Radial access increased from 4.9% in the first quarter of 2009 to 11.9% in the last quarter of 2010. Significant independent predictors were higher body surface area, non-Hispanic ethnicity, Caucasian race, stable hemodynamic state, ejection fraction <30% and ≥50% onset of STEMI from 12 to 23 h before the index procedure, and peripheral vascular disease. Mortality was not related to access site after adjustment for covariates (for radial vs. femoral access, adjusted odds ratio: 0.86, 95% confidence interval: 0.59 to 1.25), but the radial access site was trending toward lower mortality for the 9 hospitals that used it for more than 10% of their patients (adjusted odds ratio: 0.61, 95% confidence interval: 0.36 to 1.02). Conclusions: The use of a radial access site for PCI in STEMI patients increased between 2009 and 2010, but was still infrequent in 2010, and was used for lower-risk STEMI patients. There was no significant difference in mortality by access site, but there was a trend toward a mortality advantage for patients with a radial access site among hospitals that used it relatively frequently.
AB - Objectives: This study sought to determine the utilization and outcomes for radial access for percutaneous coronary intervention (PCI) for ST-segment elevation acute myocardial infarction (STEMI) in common practice. Background: Radial access for PCI has been studied considerably, but mostly in clinical trials. Methods: All patients undergoing PCI for STEMI in 2009 to 2010 in New York were studied to determine the frequency and the patient-level predictors of radial access. Differences in in-hospital/30-day mortality between radial and femoral access were also studied. Results: Radial access increased from 4.9% in the first quarter of 2009 to 11.9% in the last quarter of 2010. Significant independent predictors were higher body surface area, non-Hispanic ethnicity, Caucasian race, stable hemodynamic state, ejection fraction <30% and ≥50% onset of STEMI from 12 to 23 h before the index procedure, and peripheral vascular disease. Mortality was not related to access site after adjustment for covariates (for radial vs. femoral access, adjusted odds ratio: 0.86, 95% confidence interval: 0.59 to 1.25), but the radial access site was trending toward lower mortality for the 9 hospitals that used it for more than 10% of their patients (adjusted odds ratio: 0.61, 95% confidence interval: 0.36 to 1.02). Conclusions: The use of a radial access site for PCI in STEMI patients increased between 2009 and 2010, but was still infrequent in 2010, and was used for lower-risk STEMI patients. There was no significant difference in mortality by access site, but there was a trend toward a mortality advantage for patients with a radial access site among hospitals that used it relatively frequently.
KW - PCI
KW - STEMI
KW - radial access
UR - http://www.scopus.com/inward/record.url?scp=84896548200&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896548200&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2013.10.020
DO - 10.1016/j.jcin.2013.10.020
M3 - Article
C2 - 24529933
AN - SCOPUS:84896548200
SN - 1936-8798
VL - 7
SP - 276
EP - 283
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 3
ER -